Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study
A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of the ReCET™ System in Adult Patients with Type 2 Diabetes
MINNEAPOLIS, Jan. 31, 2024 /PRNewswire/ — Endogenex, Inc., a clinical stage medical devi… อ่านเพิ่ม